Zacks Upgrades Alexion Pharmaceuticals to "Outperform" (ALXN) Junction Report ... development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hematology, nephrology (including transplant rejection), neurology, ... |
